Bifidobacterium pseudocatenulatum capsular exopolysaccharide enhances systemic anti-tumour immunity in pre-clinical breast cancer
Christopher A. Price, Alicia D. Nicklin, Magdalena Kujawska, Todor T. Koev, Nilda Ilker, Wesley J. Fowler, Alastair M. McKee, Luke J Mitchell, Mitchel Rowe, James A.G.E. Taylor, Christopher J. Benwell, Sally A. Dreger, Julia Mueller, Lindsay J. Hall, Stephen David Robinson
This study shows that Bifidobacterium pseudocatenulatum 210 EPS enhances anti-tumour immunity and improves cancer therapy responses in pre-clinical models.
bioRxiv · Sep 23, 2024 · PreprintCancer Biology